This results from a failure of the body to produce insulin, and people with Type 1 diabetes must utilize exogenous insulin via regular injections or a continuous infusion to maintain blood glucose levels within a “prescribed target range” in order to limit the risk of developing long term complications associated with this condition (3). This evidence concerns the gene INS and type 1 diabetes mellitus.